Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-001227
Filing Date
2021-09-22
Accepted
2021-09-22 20:43:25
Documents
1
Period of Report
2021-09-22

Document Format Files

Seq Description Document Type Size
1 kintara_fm4sep222021.html 4  
1 kintara_fm4sep222021.xml 4 4010
  Complete submission text file 0000905718-21-001227.txt   5536
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6275 NANCY RIDGE DRIVE, SUITE 110 SAN DIEGO CA 92121
Business Address
Murphy Keith (Reporting) CIK: 0001536583 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 211270741